TechNavio today launched its report Global Rheumatoid Arthritis (RA) Drugs Market 2011“2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers™ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio™s Healthcare team said, Though the Global RA Drugs market has matured, most of the innovations by the biopharmaceutical and pharmaceutical vendors are either still in the development stages or awaiting approval. For instance, Denosumab from Amgen is in the second phase of development and it is expected to enter the RA Drugs market soon. Biologic drugs create better opportunities for vendors to modulate disease progression and alleviate the chronic cycle of inflammation and pathology. Both leading vendors and small and domestic vendors are strengthening their position in the market by introducing new and effective biologic drugs. Therefore, the introduction of new products that are at present in the development stages will have a major impact on the market.
According to the report, a major trend in the Global RA Drugs market at present is the use of a combination of therapies to treat patients with RA. Many rheumatologists agree that biologic drugs are most effective when combined with surgery and physical therapy. Furthermore, DMARDs are also combined with biologic agents, which help to reduce the pain in the joints and minimize the damage and inflammation of the joints caused by the disease.
Further, the report also discusses that the availability of alternative treatments limits the usage of RA drugs, posing a challenge to the Global RA Drugs market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/global-rheumatoid-arthritis-drugs-marke…
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report “ Global Rheumatoid Arthritis Drugs Market 2011“2015
